 Study TMC114-C214 is a randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114 boosted with low dose ritonavir RTV versus Kaletra LPVRTV in lopinavir-naïve treatment-experienced HIV-1 infected patients. 